Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group-Reference-Cited by-同舟云学术

Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group

Published:2020-06-25 Issue:4 Volume:38 Page:446-455
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Le Bris Yannick¹²^ORCID,Magrangeas Florence²,Moreau Anne³,Chiron David²,Guérin‐Charbonnel Catherine²⁴,Theisen Olivier¹,Pichon Olivier⁵,Canioni Danielle⁶,Burroni Barbara⁷,Maisonneuve Hervé⁸,Thieblemont Catherine⁹,Oberic Lucie¹⁰^ORCID,Gyan Emmanuel¹¹,Pellat‐Deceunynck Catherine²,Hermine Olivier¹²,Delfau‐Larue Marie‐Hélène¹³^ORCID,Tessoulin Benoît²¹⁴^ORCID,Béné Marie‐Christine¹²^ORCID,Minvielle Stéphane²,Le Gouill Steven²¹⁴

Affiliation:

1. Hematology Biology Department Nantes University Hospital Nantes France

2. CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes Nantes France

3. Pathology Department Nantes University Hospital, now in Centre Hospitalier Départemental de Vendée La Roche sur Yon France

4. Institut de Cancérologie de l'Ouest, U892 Saint‐Herblain France

5. Genetic Department Nantes University Hospital Nantes France

6. Pathology Department Necker University Hospital Paris France

7. Pathology Department Cochin University Hospital Paris France

8. Hematology Clinic, Centre Hospitalier Départemental de Vendée La Roche sur Yon France

9. Clinical Hematology Department Saint Louis University Hospital Paris France

10. Clinical Hematology Department IUCT Oncopole, Toulouse University Hospital Toulouse France

11. Clinical Hematology Department Tours University Hospital Tours France